Velarion Records
Free. Unsubscribe any time.

CG Oncology, Inc. (CGON)

CG Oncology, Inc. filed 23 Form 4 statements naming a Rule 10b5-1 trading plan in the 2025 filing year, by 2 reporting owners, covering 30 transactions and 145,197 shares. 22 carry the SEC's AFF10B5ONE flag; 1 name a plan only in a footnote. 7 results prints are on file in the same window.

What stands out

Trades in CG Oncology, Inc. 30

Adoption dates in CG Oncology, Inc. 4

Results prints in CG Oncology, Inc. 7

Trades before a print in CG Oncology, Inc. 0

Interval to CG Oncology, Inc.’s next reported results date

How the interval and sources are counted →

Adoption dates CG Oncology, Inc. states

Filing text: “10b5-1 trading plan adopted by the Reporting Person on September 6, 2024”

Reported results dates on file

A proxy statement is on file for this company in the same window, which is where a company states its own trading policy.

Other companies with plan records

Sources: SEC EDGAR full-text search and the SEC submissions API.